National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 3) (No. PB 22 of 2013)

Link to law: https://www.comlaw.gov.au/Details/F2013L00678

 
PB 22 of 2013
National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 3)1
National Health Act 1953
I, ADRIANA PLATONA, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 22 April 2013
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 3).
            (2)        This Instrument may also be cited as PB 22 of 2013.
2          Commencement
            This Instrument commences on 1 May 2013.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1]      Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity 25]
(a)           omit from the column headed “Determined Price”:     25.75     substitute:             16.05
(b)           omit from the column headed “Claimed Price”:          27.52     substitute:             17.15
[2]      Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity 90]
omit from the column headed “Claimed Price”:          95.29     substitute:             59.39
[3]      Schedule 1, entry for Aciclovir in the form Tablet 800 mg
(a)           omit from the column headed “Determined Price”:     112.15   substitute:             69.90
(b)           omit from the column headed “Claimed Price”:          113.41   substitute:             70.69
[4]      Schedule 1, omit entry for Alendronic Acid
[5]      Schedule 1, entry for Allopurinol in the form Tablet 100 mg [Pricing Quantity/Pack Quantity 100]
omit from the column headed “Determined Price”:     2.61        substitute:             2.14
[6]      Schedule 1, entry for Allopurinol in the form Tablet 100 mg [Pricing Quantity/Pack Quantity 200]
omit from the column headed “Claimed Price”:          7.72        substitute:             6.33
[7]      Schedule 1, entry for Allopurinol in the form Tablet 300 mg
(a)           omit from the column headed “Determined Price”:     3.08        substitute:             2.52
(b)           omit from the column headed “Claimed Price”:          5.39        substitute:             4.41
[8]      Schedule 1, entry for Alprazolam in the form Tablet 250 micrograms
(a)           omit from the column headed “Determined Price”:     1.99        substitute:             1.74
(b)           omit from the column headed “Claimed Price”:          3.57        substitute:             3.12
[9]      Schedule 1, entry for Alprazolam in the form Tablet 500 micrograms
(a)           omit from the column headed “Determined Price”:     3.22        substitute:             2.81
(b)           omit from the column headed “Claimed Price”:          4.80        substitute:             4.19
 
[10]    Schedule 1, entry for Alprazolam in the form Tablet 1 mg
(a)           omit from the column headed “Determined Price”:     5.61        substitute:             4.89
(b)           omit from the column headed “Claimed Price”:          7.18        substitute:             6.26
[11]    Schedule 1, entry for Alprazolam in the form Tablet 2 mg
(a)           omit from the column headed “Determined Price”:     8.69        substitute:             7.58
(b)           omit from the column headed “Claimed Price”:          10.27     substitute:             8.96
[12]    Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)
(a)           omit from the column headed “Determined Price”:     4.07        substitute:             2.44
(b)           omit from the column headed “Claimed Price”:          7.11        substitute:             4.26
[13]    Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)
(a)           omit from the column headed “Determined Price”:     7.14        substitute:             4.28
(b)           omit from the column headed “Claimed Price”:          11.59     substitute:             6.95
[14]  Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing
125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
(a)           omit from the column headed “Determined Price”:     1.82        substitute:             1.47
(b)           omit from the column headed “Claimed Price”:          3.10        substitute:             2.50
[15]  Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
(a)           omit from the column headed “Determined Price”:     2.60        substitute:             2.10
(b)           omit from the column headed “Claimed Price”:          3.88        substitute:             3.13
[16]  Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate)
with 125 mg clavulanic acid (as potassium clavulanate)
(a)           omit from the column headed “Determined Price”:     2.96        substitute:             2.40
(b)           omit from the column headed “Claimed Price”:          4.23        substitute:             3.43
[17]  Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate)
with 125 mg clavulanic acid (as potassium clavulanate)
(a)           omit from the column headed “Determined Price”:     4.21        substitute:             3.41
(b)           omit from the column headed “Claimed Price”:          5.48        substitute:             4.44
[18]    Schedule 1, entry for Atenolol
(a)           omit from the column headed “Determined Price”:     1.93        substitute:             1.55
(b)           omit from the column headed “Claimed Price”:          4.24        substitute:             3.41
[19]    Schedule 1, entry for Baclofen in the form Tablet 10 mg
(a)           omit from the column headed “Determined Price”:     13.59     substitute:             12.15
(b)           omit from the column headed “Claimed Price”:          14.80     substitute:             13.23
[20]    Schedule 1, entry for Baclofen in the form Tablet 25 mg
(a)           omit from the column headed “Determined Price”:     29.72     substitute:             26.56
(b)           omit from the column headed “Claimed Price”:          30.92     substitute:             27.63
[21]    Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity 20]
(a)           omit from the column headed “Determined Price”:     28.29     substitute:             23.79
(b)           omit from the column headed “Claimed Price”:          31.05     substitute:             26.11
[22]    Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 50 mg [Pricing Quantity/Pack Quantity 50]
omit from the column headed “Claimed Price”:          72.05     substitute:             60.59
[23]    Schedule 1, entry for Cyproterone in the form Tablet containing cyproterone acetate 100 mg
(a)           omit from the column headed “Determined Price”:     110.21   substitute:             92.66
(b)           omit from the column headed “Claimed Price”:          111.32   substitute:             93.60
[24]    Schedule 1, entry for Desferrioxamine in the form Powder for injection containing desferrioxamine mesylate 500 mg
(a)           omit from the column headed “Determined Price”:     93.14     substitute:             81.02
(b)           omit from the column headed “Claimed Price”:          100.86   substitute:             87.74
[25]    Schedule 1, entry for Desferrioxamine in the form Powder for injection containing desferrioxamine mesylate 2 g
(a)           omit from the column headed “Determined Price”:     37.25     substitute:             32.40
(b)           omit from the column headed “Claimed Price”:          37.63     substitute:             32.73
[26]    Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg
(a)           omit from the column headed “Determined Price”:     2.56        substitute:             2.03
(b)           omit from the column headed “Claimed Price”:          3.50        substitute:             2.78
[27]    Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg
(a)           omit from the column headed “Determined Price”:     3.56        substitute:             2.83
(b)           omit from the column headed “Claimed Price”:          5.45        substitute:             4.33
[28]  Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Pricing Quantity/Pack Quantity 7]
(a)           omit from the column headed “Determined Price”:     1.57        substitute:             1.23
(b)           omit from the column headed “Claimed Price”:          3.88        substitute:             3.04
[29]  Schedule 1, entry for Doxycycline in the form Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
[Pricing Quantity/Pack Quantity 21]
omit from the column headed “Claimed Price”:          7.85        substitute:             6.15
[30]    Schedule 1, entry for Doxycycline in the form Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)
(a)           omit from the column headed “Listed Drug”:               Doxycycline [drug name repeated]
(b)           omit from the column headed “Determined Price”:     2.80        substitute:             2.19
(c)        omit from the column headed “Claimed Price”:          5.15        substitute:             4.03
[31]    Schedule 1, entry for Doxycycline in the form Tablet 50 mg (as hydrochloride)
(a)           omit from the column headed “Determined Price”:     2.80        substitute:             2.19
(b)           omit from the column headed “Claimed Price”:          4.37        substitute:             3.42
[32]    Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 50 mg
(a)           omit from the column headed “Determined Price”:     8.76        substitute:             7.59
(b)           omit from the column headed “Claimed Price”:          10.62     substitute:             9.20
[33]    Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 100 mg
(a)           omit from the column headed “Determined Price”:     13.28     substitute:             11.50
(b)           omit from the column headed “Claimed Price”:          15.14     substitute:             13.11
[34]    Schedule 1, entry for Gabapentin in the form Capsule 100 mg
(a)           omit from the column headed “Determined Price”:     9.51        substitute:             7.56
(b)           omit from the column headed “Claimed Price”:          11.09     substitute:             8.82
 
[35]    Schedule 1, entry for Gabapentin in the form Capsule 300 mg
(a)           omit from the column headed “Determined Price”:     31.78     substitute:             25.27
(b)           omit from the column headed “Claimed Price”:          33.59     substitute:             26.71
[36]    Schedule 1, entry for Gabapentin in the form Capsule 400 mg
(a)           omit from the column headed “Determined Price”:     43.34     substitute:             34.46
(b)           omit from the column headed “Claimed Price”:          44.99     substitute:             35.77
[37]    Schedule 1, entry for Gabapentin in the form Tablet 600 mg
(a)           omit from the column headed “Determined Price”:     68.80     substitute:             54.70
(b)           omit from the column headed “Claimed Price”:          70.45     substitute:             56.01
[38]    Schedule 1, entry for Gabapentin in the form Tablet 800 mg
(a)           omit from the column headed “Determined Price”:     91.72     substitute:             72.92
(b)           omit from the column headed “Claimed Price”:          93.37     substitute:             74.23
[39]    Schedule 1, entry for Glimepiride in the form Tablet 1 mg
(a)           omit from the column headed “Determined Price”:     1.51        substitute:             1.32
(b)           omit from the column headed “Claimed Price”:          3.78        substitute:             3.30
[40]    Schedule 1, entry for Glimepiride in the form Tablet 2 mg
(a)           omit from the column headed “Determined Price”:     2.89        substitute:             2.53
(b)           omit from the column headed “Claimed Price”:          5.17        substitute:             4.53
[41]    Schedule 1, entry for Glimepiride in the form Tablet 3 mg
(a)           omit from the column headed “Determined Price”:     3.70        substitute:             3.23
(b)           omit from the column headed “Claimed Price”:          5.97        substitute:             5.21
[42]    Schedule 1, entry for Glimepiride in the form Tablet 4 mg
(a)           omit from the column headed “Determined Price”:     4.53        substitute:             3.96
(b)           omit from the column headed “Claimed Price”:          6.79        substitute:             5.94
 
[43]  Schedule 1, entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 250 micrograms
(anhydrous) in 1 mL single dose units, 30
(a)           omit from the column headed “Determined Price”:     11.86     substitute:             9.84
(b)           omit from the column headed “Claimed Price”:          12.13     substitute:             10.06
[44]  Schedule 1, entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 500 micrograms
(anhydrous) in 1 mL single dose units, 30
(a)           omit from the column headed “Determined Price”:     14.02     substitute:             11.63
(b)           omit from the column headed “Claimed Price”:          14.29     substitute:             11.85
[45]    Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Imdur Durule]
(a)           omit from the column headed “Determined Price”:     4.45        substitute:             3.98
(b)           omit from the column headed “Claimed Price”:          7.48        substitute:             6.69
[46]    Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 60 mg (sustained release) [Monodur 60 mg]
(a)           omit from the column headed “Determined Price”:     4.45        substitute:             3.98
(b)           omit from the column headed “Claimed Price”:          6.67        substitute:             5.97
[47]    Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 120 mg (sustained release)
(a)           omit from the column headed “Determined Price”:     10.54     substitute:             9.42
(b)           omit from the column headed “Claimed Price”:          13.57     substitute:             12.13
[48]    Schedule 1, entry for Lactulose
(a)           omit from the column headed “Determined Price”:     4.52        substitute:             3.81
(b)           omit from the column headed “Claimed Price”:          5.49        substitute:             4.63
[49]    Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg
(a)           omit from the column headed “Determined Price”:     5.05        substitute:             3.55
(b)           omit from the column headed “Claimed Price”:          7.20        substitute:             5.06
[50]    Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg
(a)           omit from the column headed “Determined Price”:     8.43        substitute:             5.93
(b)           omit from the column headed “Claimed Price”:          10.57     substitute:             7.43
 
[51]    Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
(a)        align values under the column headings “Pricing Quantity/Pack Quantity”; Determined Quantity”; and “Claimed Price” for the brand “Diabex”
(b)        omit:
 
 
 
Glucophage
100
4.24
4.94
[52]    Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Betaloc]
(a)           omit from the column headed “Determined Price”:     2.75        substitute:             2.45
(b)           omit from the column headed “Claimed Price”:          5.79        substitute:             5.16
[53]    Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Lopresor 50]
(a)           omit from the column headed “Determined Price”:     2.75        substitute:             2.45
(b)           omit from the column headed “Claimed Price”:          4.79        substitute:             4.27
[54]    Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg [Betaloc]
(a)           omit from the column headed “Determined Price”:     3.51        substitute:             3.13
(b)           omit from the column headed “Claimed Price”:          6.55        substitute:             5.84
[55]    Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg [Lopresor 100]
(a)           omit from the column headed “Determined Price”:     3.51        substitute:             3.13
(b)           omit from the column headed “Claimed Price”:          5.53        substitute:             4.93
[56]    Schedule 1, entry for Mirtazapine in the form Tablet 1 5 mg (orally disintegrating)
(a)           omit from the column headed “Form”:           1 5 mg                  substitute:             15 mg
(b)           omit from the column headed “Determined Price”:     13.75     substitute:             10.29
(c)        omit from the column headed “Claimed Price”:        14.72    substitute:          11.02
[57]    Schedule 1, entry for Mirtazapine in the form Tablet 30 mg
(a)           omit from the column headed “Determined Price”:     11.96     substitute:             8.95
(b)        omit from the column headed “Claimed Price”:        14.79    substitute:          11.07
[58]    Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)
(a)           omit from the column headed “Determined Price”:     18.34     substitute:             13.72
(b)        omit from the column headed “Claimed Price”:        19.32    substitute:          14.45
[59]    Schedule 1, entry for Mirtazapine in the form Tablet 45 mg
(a)           omit from the column headed “Determined Price”:     19.95     substitute:             14.93
(b)        omit from the column headed “Claimed Price”:        22.79    substitute:          17.06
[60]    Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)
(a)           omit from the column headed “Determined Price”:     27.64     substitute:             20.68
(b)        omit from the column headed “Claimed Price”:        28.72    substitute:          21.49
[61]    Schedule 1, entry for Moclobemide in the form Tablet 150 mg
(a)           omit from the column headed “Determined Price”:     7.66        substitute:             6.63
(b)        omit from the column headed “Claimed Price”:        8.11      substitute:          7.02
[62]    Schedule 1, entry for Moclobemide in the form Tablet 300 mg
(a)           omit from the column headed “Determined Price”:     14.76     substitute:             12.77
(b)        omit from the column headed “Claimed Price”:        15.65    substitute:          13.54
[63]    Schedule 1, entry for Norfloxacin in the form Tablet 400 mg
(a)           omit from the column headed “Determined Price”:     5.92        substitute:             4.94
(b)        omit from the column headed “Claimed Price”:        9.09      substitute:          7.59
[64]    Schedule 1, entry for Pindolol in the form Tablet 15 mg
(a)           omit from the column headed “Determined Price”:     5.60        substitute:             3.72
(b)        omit from the column headed “Claimed Price”:        7.67      substitute:          5.10
[65]    Schedule 1, entry for Ranitidine
omit:
 
Syrup 150 mg (as hydrochloride) per 10 mL, 300 mL
Oral
Zantac Syrup
1
7.32
8.21
[66]    Schedule 1, entry for Ranitidine in the form Tablet 150 mg (as hydrochloride)
(a)           omit from the column headed “Determined Price”:     8.80        substitute:             6.46
(b)        omit from the column headed “Claimed Price”:        10.70    substitute:          7.85
 
[67]    Schedule 1, entry for Ranitidine in the form Tablet 300 mg (as hydrochloride)
(a)           omit from the column headed “Determined Price”:     8.80        substitute:             6.46
(b)        omit from the column headed “Claimed Price”:        10.70    substitute:          7.85
[68]    Schedule 1, entry for Ranitidine
omit:
 
Tablet, effervescent, 150 mg (as hydrochloride)
Oral
Zantac
30
4.11
5.68
[69]    Schedule 1, entry for Salbutamol in the form Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30
(a)           omit from the column headed “Determined Price”:     4.81        substitute:             4.15
(b)           omit from the column headed “Claimed Price”:          5.36        substitute:             4.62
(c)        align values under the column headings “Pricing Quantity/Pack Quantity”; Determined Quantity”; and “Claimed Price”
[70]    Schedule 1, entry for Salbutamol in the form Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30
(a)           omit from the column headed “Determined Price”:     5.08        substitute:             4.38
(b)           omit from the column headed “Claimed Price”:          5.63        substitute:             4.85
[71]    Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 80 mg
(a)           omit from the column headed “Determined Price”:     5.13        substitute:             4.38
(b)           omit from the column headed “Claimed Price”:          9.17        substitute:             7.83
[72]    Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride 160 mg
(a)           omit from the column headed “Determined Price”:     11.00     substitute:             9.40
(b)           omit from the column headed “Claimed Price”:          15.04     substitute:             12.85
[73]    Schedule 1, entry for Sucralfate
(a)           omit from the column headed “Determined Price”:     14.80     substitute:             11.79
(b)           omit from the column headed “Claimed Price”:          16.46     substitute:             13.11
[74]    Schedule 1, entry for Sumatriptan
(a)           omit from the column headed “Determined Price”:     7.26        substitute:             6.09
(b)           omit from the column headed “Claimed Price”:          8.01        substitute:             6.72
[75]    Schedule 1, entry for Tamoxifen
(a)           omit from the column headed “Determined Price”:     21.62     substitute:             14.54
(b)           omit from the column headed “Claimed Price”:          23.16     substitute:             15.58
[76]    Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg
(a)           omit from the column headed “Determined Price”:     1.59        substitute:             1.28
(b)           omit from the column headed “Claimed Price”:          3.54        substitute:             2.85
[77]    Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg
(a)           omit from the column headed “Determined Price”:     4.32        substitute:             3.48
(b)           omit from the column headed “Claimed Price”:          7.96        substitute:             6.41
[78]    Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg
(a)           omit from the column headed “Determined Price”:     5.82        substitute:             4.69
(b)           omit from the column headed “Claimed Price”:          10.17     substitute:             8.19
[79]    Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg
(a)           omit from the column headed “Determined Price”:     7.09        substitute:             5.71
(b)           omit from the column headed “Claimed Price”:          12.01     substitute:             9.67
[80]    Schedule 1, entry for Trandolapril in the form Capsule 500 micrograms
(a)           omit from the column headed “Determined Price”:     1.75        substitute:             1.57
(b)           omit from the column headed “Claimed Price”:          2.87        substitute:             2.57
[81]    Schedule 1, entry for Trandolapril in the form Capsule 1 mg
(a)           omit from the column headed “Determined Price”:     4.63        substitute:             4.16
(b)           omit from the column headed “Claimed Price”:          5.78        substitute:             5.19
[82]    Schedule 1, entry for Trandolapril in the form Capsule 2 mg
(a)           omit from the column headed “Determined Price”:     5.59        substitute:             5.02
(b)           omit from the column headed “Claimed Price”:          8.02        substitute:             7.20
[83]    Schedule 1, entry for Trandolapril in the form Capsule 4 mg
(a)           omit from the column headed “Determined Price”:     10.49     substitute:             9.42
(b)           omit from the column headed “Claimed Price”:          12.92     substitute:             11.60
[84]    Schedule 2, omit entry for Ranitidine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.comlaw.gov.au
Read Entire Law on www.comlaw.gov.au